Singapore Steps Up Enforcement and Crackdown on E-Cigarettes

Regulations by 2FIRSTS.ai
Dec.20.2023
Singapore Steps Up Enforcement and Crackdown on E-Cigarettes
Singapore's health ministry aims to crack down on the sale and use of e-cigarettes, despite a ban, by ramping up enforcement efforts.

According to a report by Singapore's Lianhe Zaobao on December 19, the Singapore Ministry of Health has pointed out that despite the ban on the sale and use of e-cigarettes in the country, there are still avenues for the public to purchase them. In response to this situation, the Ministry of Health plans to intensify joint enforcement efforts and raising public awareness to combat the circulation of e-cigarettes.

 

In a joint statement issued on December 19th last year, the Ministry of Health and the Health Science Bureau announced their findings that the public can still obtain e-cigarettes through chatting applications such as Telegram or while traveling abroad. In an effort to prevent further deterioration of the e-cigarette issue in the country, the Ministry of Health, along with other government agencies, intends to strengthen enforcement measures and awareness campaigns regarding e-cigarettes.

 

In recent times, the Health Sciences Authority (HSA) has announced a joint operation with the Immigration and Checkpoints Authority (ICA) to carry out enforcement measures at ports, land checkpoints, and airports, starting from Changi Airport. The primary objective of this operation is to crack down on incoming passengers carrying e-cigarettes, with violators being subject to fines. The HSA will also collaborate with the Ministry of Communications and Information and the Infocomm Media Development Authority to enhance the monitoring and prohibition of e-cigarette online sales and advertising.

 

In addition, the Ministry of Health, in collaboration with the Ministry of Education, the National Environmental Agency, the National Parks Board, and the Singapore Police Force, has ramped up enforcement efforts regarding the possession and use of e-cigarettes. Since December 1st of last year, enforcement officers from the Environmental Agency have been authorized to take action against individuals found using or possessing e-cigarettes, with some cases being passed on to the Health Sciences Authority for further investigation.

 

Inspections at public places such as central business districts, shopping centers, parks, smoking areas, bars, and clubs will also be intensified, with violators facing on-the-spot fines. In schools, if students are found using or in possession of e-cigarettes, the school authorities will confiscate the e-cigarette, inform parents, and report the incident to the Department of Health, to ensure strict punishment for such violations.

 

According to the latest data released by the Health Science Bureau, from 2018 to 2022, a total of 860 individuals have been involved in the sale and smuggling of e-cigarettes and their accessories, with 145 of them being brought to court. Last year, the number of arrests for using and possessing e-cigarettes reached 4,916, nearly triple the figure from 2020. In the period from April to August this year, 18 individuals were sentenced for selling e-cigarettes and their accessories.

 

According to Minister Wong Yi Kang's response to written queries in Parliament last November, approximately 20% of the individuals arrested for purchasing or possessing e-cigarettes in the first nine months of last year were under the age of 18.

 

According to tobacco regulations, the import, distribution, or sale of e-cigarettes is considered illegal. First-time offenders can face a maximum fine of SGD 10,000 or six months of imprisonment, or both. Repeat offenders can be fined SGD 20,000, imprisoned for one year, or both. Individuals found in possession of, using, or purchasing e-cigarettes may face a maximum fine of SGD 2,000.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Product | Juul Labs Launches Upgraded JUUL2 Kit in UK With Four Pods at £9.99 and USB-C Charging
Juul Labs UK has introduced an upgraded JUUL2 Starter Kit for the UK market in October 2026, retaining a recommended retail price of £9.99 while doubling the number of included pods from two to four. The kit contains Crisp Menthol, Virginia Tobacco, Mango and Watermelon pods. The updated device replaces the previous proprietary charging dock with a USB-C port and offers longer battery life. The kit also features reduced packaging and retains a two-year limited warranty. Distribution is scheduled through major UK retailers, wholesalers, convenience stores and the JUUL UK website.
product
Oct.15
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
Altria’s USSTC Starts $250 Million Kentucky Expansion, Adding More Than 200 Jobs
U.S. Smokeless Tobacco Company, an Altria Group company, has broken ground on an approximately $250 million manufacturing expansion in Hopkinsville, Kentucky. The roughly 270,000-square-foot facility is expected to create more than 200 jobs and absorb processing, manufacturing and packaging operations currently split between Hopkinsville and Nashville, Tennessee. USSTC previously said production at its Nashville facility is expected to wind down by early 2028. The project forms part of Altria’s broader effort to modernize and consolidate its U.S. smokeless tobacco manufacturing network.
Sep.10